Low income vs United Arab Emirates: Access to anti-retroviral drugs, female
Low income
85.2%
in 2024
United Arab Emirates
97.0%
in 2024
Low income rank
13th
United Arab Emirates rank
12th
Access to anti-retroviral drugs, female over time
- Low income
- United Arab Emirates
How they compare
United Arab Emirates currently reports 97.0% against 85.2% in Low income, a difference of 11.8%.
That makes United Arab Emirates's figure about 1.1 times Low income's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was United Arab Emirates ahead.
Low income ranks 13th and United Arab Emirates ranks 12th of 19 groups.
Across the 3 decades both report, Low income averaged higher in 1 and United Arab Emirates in 2.
Head to head by decade
| Decade | Low income | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 21.0% | 15.8% | United Arab Emirates |
| 2010s | 46.8% | 31.5% | 15.3% | Low income |
| 2020s | 79.0% | 85.4% | 6.4% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Low income or United Arab Emirates?
- United Arab Emirates, at 97.0% against 85.2% in Low income as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Low income and United Arab Emirates?
- 11.8%, with United Arab Emirates ahead.
- How many years of comparable data are there for Low income and United Arab Emirates?
- 25 years are reported by both, from 2000 to 2024.
- How do Low income and United Arab Emirates rank globally for access to anti-retroviral drugs, female?
- Low income ranks 13th and United Arab Emirates ranks 12th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.